| FOXA1 represses the molecular phenotype of basal breast cancer cells GM Bernardo, G Bebek, CL Ginther, ST Sizemore, KL Lozada, JD Miedler, ... Oncogene 32 (5), 554-563, 2013 | 178 | 2013 |
| Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin S Sizemore, M Cicek, N Sizemore, KP Ng, G Casey Cancer research 67 (13), 6183-6191, 2007 | 148 | 2007 |
| GABA (A) receptor pi (GABRP) stimulates basal-like breast cancer cell migration through activation of extracellular-regulated kinase 1/2 (ERK1/2) GM Sizemore, ST Sizemore, DD Seachrist, RA Keri Journal of Biological Chemistry 289 (35), 24102-24113, 2014 | 99 | 2014 |
| The forkhead box transcription factor FOXC1 promotes breast cancer invasion by inducing matrix metalloprotease 7 (MMP7) expression ST Sizemore, RA Keri Journal of Biological Chemistry 287 (29), 24631-24640, 2012 | 98 | 2012 |
| Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patients DG Hicks, BJ Yoder, S Short, S Tarr, N Prescott, JP Crowe, AE Dawson, ... Clinical cancer research 12 (22), 6702-6708, 2006 | 95 | 2006 |
| BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-κB binding site of the uPA promoter M Cicek, R Fukuyama, MS Cicek, S Sizemore, DR Welch, N Sizemore, ... Clinical & experimental metastasis 26, 229-237, 2009 | 70 | 2009 |
| Stromal PDGFR-α activation enhances matrix stiffness, impedes mammary ductal development, and accelerates tumor growth AM Hammer, GM Sizemore, VC Shukla, A Avendano, ST Sizemore, ... Neoplasia 19 (6), 496-508, 2017 | 65 | 2017 |
| Pyruvate kinase M2 regulates homologous recombination-mediated DNA double-strand break repair ST Sizemore, M Zhang, JH Cho, GM Sizemore, B Hurwitz, B Kaur, ... Cell research 28 (11), 1090-1102, 2018 | 61 | 2018 |
| Hypomethylation of the MMP7 promoter and increased expression of MMP7 distinguishes the basal-like breast cancer subtype from other triple-negative tumors ST Sizemore, GM Sizemore, CN Booth, CL Thompson, P Silverman, ... Breast cancer research and treatment 146, 25-40, 2014 | 39 | 2014 |
| Synthetic lethality of PARP inhibition and ionizing radiation is p53-dependent ST Sizemore, R Mohammad, GM Sizemore, S Nowsheen, H Yu, ... Molecular Cancer Research 16 (7), 1092-1102, 2018 | 35 | 2018 |
| Mitotic vulnerability in triple-negative breast cancer associated with LIN9 is targetable with BET inhibitors JM Sahni, SS Gayle, BM Webb, KL Weber-Bonk, DD Seachrist, S Singh, ... Cancer research 77 (19), 5395-5408, 2017 | 35 | 2017 |
| Changes in BAI1 and nestin expression are prognostic indicators for survival and metastases in breast cancer and provide opportunities for dual targeted therapies WH Meisen, S Dubin, ST Sizemore, H Mathsyaraja, K Thies, NL Lehman, ... Molecular cancer therapeutics 14 (1), 307-314, 2015 | 35 | 2015 |
| Stromal platelet–derived growth factor receptor-β signaling promotes breast cancer metastasis in the brain KA Thies, AM Hammer, BE Hildreth III, SA Steck, JM Spehar, RD Kladney, ... Cancer research 81 (3), 606-618, 2021 | 33 | 2021 |
| Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1 GM Sizemore, S Balakrishnan, AM Hammer, KA Thies, AJ Trimboli, ... Oncogene 36 (16), 2297-2308, 2017 | 32 | 2017 |
| A genome-wide pooled shRNA screen identifies PPP2R2A as a predictive biomarker for the response to ATR and CHK1 inhibitors Z Qiu, P Fa, T Liu, CB Prasad, S Ma, Z Hong, ER Chan, H Wang, Z Li, ... Cancer research 80 (16), 3305-3318, 2020 | 31 | 2020 |
| Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer DD Seachrist, ST Sizemore, E Johnson, FW Abdul-Karim, KL Weber Bonk, ... Breast Cancer Research 19, 1-10, 2017 | 30 | 2017 |
| Protein kinase C Beta in the tumor microenvironment promotes mammary tumorigenesis JA Wallace, JR Pitarresi, N Sharma, M Palettas, MC Cuitiño, ST Sizemore, ... Frontiers in oncology 4, 87, 2014 | 30 | 2014 |
| LIN9 and NEK2 are core regulators of mitotic fidelity that can be therapeutically targeted to overcome taxane resistance MS Roberts, JM Sahni, MS Schrock, KM Piemonte, KL Weber-Bonk, ... Cancer research 80 (8), 1693-1706, 2020 | 28 | 2020 |
| NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis L Wan, T Liu, Z Hong, Y Pan, ST Sizemore, J Zhang, Z Ma Breast Cancer Research 21, 1-16, 2019 | 25 | 2019 |
| The transcriptional repressor BCL11A promotes breast cancer metastasis DD Seachrist, MM Hannigan, NN Ingles, BM Webb, KL Weber-Bonk, P Yu, ... Journal of Biological Chemistry 295 (33), 11707-11719, 2020 | 23 | 2020 |
